126 related articles for article (PubMed ID: 22771978)
1. Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery.
Paulis LE; Geelen T; Kuhlmann MT; Coolen BF; Schäfers M; Nicolay K; Strijkers GJ
J Control Release; 2012 Sep; 162(2):276-85. PubMed ID: 22771978
[TBL] [Abstract][Full Text] [Related]
2. Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury.
Geelen T; Paulis LE; Coolen BF; Nicolay K; Strijkers GJ
Contrast Media Mol Imaging; 2013; 8(2):117-26. PubMed ID: 23281284
[TBL] [Abstract][Full Text] [Related]
3. Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium.
Lipinski MJ; Albelda MT; Frias JC; Anderson SA; Luger D; Westman PC; Escarcega RO; Hellinga DG; Waksman R; Arai AE; Epstein SE
Cardiovasc Revasc Med; 2016 Mar; 17(2):106-12. PubMed ID: 26874740
[TBL] [Abstract][Full Text] [Related]
4. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.
Watzinger N; Lund GK; Higgins CB; Wendland MF; Weinmann HJ; Saeed M
J Magn Reson Imaging; 2002 Dec; 16(6):633-40. PubMed ID: 12451576
[TBL] [Abstract][Full Text] [Related]
5. Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction.
Oostendorp M; Douma K; Wagenaar A; Slenter JM; Hackeng TM; van Zandvoort MA; Post MJ; Backes WH
Circulation; 2010 Feb; 121(6):775-83. PubMed ID: 20124125
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction.
Yang Z; Berr SS; Gilson WD; Toufektsian MC; French BA
Circulation; 2004 Mar; 109(9):1161-7. PubMed ID: 14967719
[TBL] [Abstract][Full Text] [Related]
7. Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study.
den Adel B; van der Graaf LM; Que I; Strijkers GJ; Löwik CW; Poelmann RE; van der Weerd L
Contrast Media Mol Imaging; 2013; 8(1):63-71. PubMed ID: 23109394
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.
Port RE; Schuster C; Port CR; Bachert P
Cancer Chemother Pharmacol; 2006 Nov; 58(5):607-17. PubMed ID: 16506037
[TBL] [Abstract][Full Text] [Related]
9. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats.
Takahama H; Minamino T; Asanuma H; Fujita M; Asai T; Wakeno M; Sasaki H; Kikuchi H; Hashimoto K; Oku N; Asakura M; Kim J; Takashima S; Komamura K; Sugimachi M; Mochizuki N; Kitakaze M
J Am Coll Cardiol; 2009 Feb; 53(8):709-17. PubMed ID: 19232905
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
[TBL] [Abstract][Full Text] [Related]
11. Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.
Langereis S; Geelen T; Grüll H; Strijkers GJ; Nicolay K
NMR Biomed; 2013 Jul; 26(7):728-44. PubMed ID: 23703874
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].
Baer FM; Theissen P; Schneider CA; Voth E; Schicha H; Sechtem U
Herz; 1994 Feb; 19(1):51-64. PubMed ID: 8150414
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction.
Scott RC; Wang B; Nallamothu R; Pattillo CB; Perez-Liz G; Issekutz A; Del Valle L; Wood GC; Kiani MF
Biotechnol Bioeng; 2007 Mar; 96(4):795-802. PubMed ID: 17051598
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium pharmacokinetics of chronic myocardial infarcts: Implications for late gadolinium-enhanced infarct imaging.
Goldfarb JW; Arnold S; Roth M
J Magn Reson Imaging; 2009 Oct; 30(4):763-70. PubMed ID: 19787722
[TBL] [Abstract][Full Text] [Related]
15. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI.
Yang Y; Connelly K; Graham JJ; Detsky J; Lee T; Walcarius R; Paul G; Wright GA; Dick AJ
J Magn Reson Imaging; 2011 Jan; 33(1):211-6. PubMed ID: 21182141
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
17. Liposome kinetics in infarcted canine myocardium.
Caride VJ; Twickler J; Zaret BL
J Cardiovasc Pharmacol; 1984; 6(6):996-1005. PubMed ID: 6084791
[TBL] [Abstract][Full Text] [Related]
18. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.
Zheng Y; Zhang H; Hu Y; Bai L; Xue J
Int J Nanomedicine; 2018; 13():6177-6188. PubMed ID: 30323598
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary injection of contrast media maps the territory of the coronary artery: an MRI technique for assessing the effects of locally delivered angiogenic therapies.
Carlsson M; Saeed M
Acad Radiol; 2008 Nov; 15(11):1354-9. PubMed ID: 18995187
[TBL] [Abstract][Full Text] [Related]
20. Phosphonate-modified GdDTPA complexes. II. Evaluation in a rat myocardial infarct model.
Adzamli IK; Johnson D; Blau M
Invest Radiol; 1991 Feb; 26(2):143-8. PubMed ID: 2055714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]